Inpharma Weekly

, Volume 1614, Issue 1, pp 5–5 | Cite as

Candesartan CREATEs promise in coronary artery disease

Meeting report


Standard Therapy Impaired Renal Function Candesartan Coronary Artery Disease Patient Major Cardiovascular Adverse Event 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2007

Personalised recommendations